MedPath

Geriatric Recovery Using Inpatient and Post-hospitalization Supplementation

Phase 1
Completed
Conditions
Aging
Interventions
Dietary Supplement: Collagen Protein
Dietary Supplement: Whey Protein
Dietary Supplement: Placebo
Registration Number
NCT03904615
Lead Sponsor
The University of Texas Medical Branch, Galveston
Brief Summary

The purpose of the study is to determine the feasibility of nutritional interventions designed to help older patients maintain physical function after being in the hospital. We will test the feasibility and effect of nutritional interventions with whey protein, collagen or placebo on functional recovery from hospitalization in community dwelling older adults.

Detailed Description

We will compare in a randomized parallel design double blind pilot phase I study the feasibility of whey protein vs. collagen vs. isocaloric placebo supplementation in older adults during an acute hospitalization for a medical condition, and the treatments' effect size on physical function after hospital discharge.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria
  • Aged 65 years or older.
  • Admitted to UTMB hospital for any acute medical condition
  • English speaking
Exclusion Criteria
  • Inability to consent
  • Bed or wheelchair bound prior to hospitalization
  • Estimated creatinine clearance 20 ml/min or less, or end stage renal disease not on dialysis
  • AST/ALT 2.5 times above the normal limit
  • Active cancer
  • Palliative care/Hospice
  • Estimated protein intake >1.2 g/kg/day during the previous 24 hours
  • Any other condition or event considered exclusionary by the PI and faculty physician

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Collagen ProteinCollagen Protein30 g of collagen protein twice daily during hospitalization and for 30 days after discharge
Whey ProteinWhey Protein30 g of whey protein twice daily during hospitalization and for 30 days after discharge
PlaceboPlacebo30 g of maltodextrin twice daily during hospitalization and for 30 days after discharge
Primary Outcome Measures
NameTimeMethod
Physical FunctionChange from baseline to 30 days after discharge

Short Physical Performance Battery (SPPB) scale, 0-12 points. 0=disabled; 12=high performance

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

UTMB Acute Care for Elders Unit

🇺🇸

Galveston, Texas, United States

Jennie Sealy Hospital

🇺🇸

Galveston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath